Mixed trend on the daily chart: above its 200-day average, below its 50-day · 50-day above the 200-day · SuperTrend down since Jul 20 · below the Ichimoku cloud · RSI 33 · MACD below its signal
None of the 29 investors followed here reported a position in IBT.L in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a IBT.L trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 24, 2026 | Henderson (Alexa H) | Bought at price 15.22 per share. | 101 | $1.54K |
| Aug 24, 2026 | Cornish-Bowden (Kate) | Bought at price 15.19 per share. | 233 | $3.54K |
| Jul 23, 2026 | International Biotechnology Trust Plc | Buy Back at price 14.44 per share. | 50K | $722.05K |
| Jul 22, 2026 | International Biotechnology Trust Plc | Buy Back at price 14.44 per share. | 100K | $1.44M |
| Jul 21, 2026 | Border To Coast Pensions Partnership Limited | — | 2.16M | — |
| Jul 7, 2026 | International Biotechnology Trust Plc | Buy Back at price 15.80 per share. | 25K | $394.88K |
| Apr 29, 2026 | International Biotechnology Trust Plc | — | 0 | — |
| Apr 6, 2026 | International Biotechnology Trust Plc | Buy Back at price 12.49 per share. | 15K | $187.40K |
| Apr 1, 2026 | International Biotechnology Trust Plc | Buy Back at price 12.35 per share. | 30K | $370.50K |
| Mar 31, 2026 | International Biotechnology Trust Plc | Buy Back at price 12.33 per share. | 30K | $369.99K |
| Jan 26, 2026 | Henderson (Alexa H) | Bought at price 13.35 per share. | 115 | $1.53K |
| Jan 26, 2026 | Cornish-Bowden (Kate) | Bought at price 13.29 per share. | 265 | $3.52K |
| Nov 27, 2025 | International Biotechnology Trust Plc | — | 0 | — |
| Nov 24, 2025 | International Biotechnology Trust Plc | Buy Back at price 12.01 per share. | 25.8K | $310.37K |
| Nov 18, 2025 | International Biotechnology Trust Plc | Buy Back at price 11.79 per share. | 100K | $1.18M |
| Nov 10, 2025 | International Biotechnology Trust Plc | Buy Back at price 11.15 per share. | 22.5K | $250.90K |
| Nov 9, 2025 | International Biotechnology Trust Plc | Buy Back at price 11.17 per share. | 25K | $279.27K |
| Nov 6, 2025 | International Biotechnology Trust Plc | Buy Back at price 10.99 per share. | 100K | $1.10M |
| Nov 5, 2025 | International Biotechnology Trust Plc | Buy Back at price 10.97 per share. | 200K | $2.19M |
| Nov 4, 2025 | Charles Stanley Group Plc | — | 0 | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 3.6 | 1.8 | -13.0 | 8.4 | 16.7 | -2.1 | -6.8 | 11.3 | -1.3 | -9.8 | +4.8% | ||
| 2025 | 6.5 | -5.5 | -10.5 | 0.2 | 2.2 | -6.4 | 9.2 | 18.2 | 1.0 | 12.3 | 18.6 | -5.5 | +41.3% |
| 2024 | -4.6 | 3.8 | 8.6 | -17.0 | 1.6 | 17.7 | -5.5 | 11.9 | -13.2 | 0.0 | 18.8 | -15.1 | −1.3% |
| 2023 | -2.9 | -1.6 | -3.9 | 4.2 | -4.3 | -1.1 | -2.1 | 0.6 | -0.3 | -12.8 | 3.2 | 19.5 | −4.3% |
| 2022 | -15.6 | 0.8 | 0.5 | 2.0 | -4.9 | 6.8 | 8.2 | -9.0 | 1.3 | -1.5 | 6.5 | 4.3 | −3.4% |
| 2021 | -1.9 | -2.8 | -5.3 | 0.3 | -2.5 | 0.7 | 2.4 | -2.0 | 0.8 | 5.8 | -6.0 | 2.3 | −8.5% |
| 2020 | -6.8 | 10.1 | -6.7 | 13.1 | 15.7 | -1.5 | -4.7 | -0.3 | 9.0 | -2.1 | 5.2 | -0.4 | +31.4% |
| 2019 | 7.0 | 1.0 | 4.5 | -2.7 | -2.2 | 5.7 | 0.7 | -3.2 | -4.2 | -0.3 | 9.7 | -5.8 | +9.1% |
| 2018 | -1.6 | -4.6 | -0.3 | -4.9 | 7.0 | 8.8 | 3.2 | 1.8 | 1.7 | -14.7 | 3.6 | -6.7 | −8.7% |
| 2017 | -7.8 | 7.6 | 1.0 | 5.5 | -9.0 | 5.1 | 3.7 | 0.1 | 2.3 | -6.0 | 1.5 | 2.5 | +4.9% |
| 2016 | -9.9 | -12.8 | -3.3 | 17.5 | -6.8 | 1.7 | 27.9 | -15.0 | 10.1 | -2.4 | 4.6 | 6.3 | +9.9% |
| 2015 | 24.5 | 3.7 | -5.6 | -5.1 | 21.3 | -13.0 | 7.8 | -5.2 | -17.5 | 21.5 | -5.2 | 3.2 | +22.2% |
| 2014 | 2.3 | 8.1 | -15.2 | -3.4 | 24.7 | -11.5 | -3.1 | 35.8 | -18.4 | 20.3 | 22.3 | -6.3 | +48.2% |
| 2013 | 7.0 | 1.2 | 29.0 | -11.2 | 4.2 | 11.4 | -6.7 | 16.5 | -8.5 | 5.4 | 8.1 | -8.4 | +49.5% |
| 2012 | -4.0 | 4.1 | 15.9 | -13.3 | 0.1 | 20.3 | -8.3 | 0.6 | 16.7 | -13.2 | -5.2 | 1.9 | +9.2% |
| 2011 | 1.5 | -0.5 | 3.6 | 14.4 | -12.7 | 0.5 | 12.5 | -17.2 | 1.7 | 3.8 | 0.0 | 21.3 | +25.2% |
| 2010 | 23.9 | 4.1 | -14.0 | 0.4 | -1.4 | 2.4 | 11.7 | -15.4 | -0.7 | 23.6 | -16.5 | 6.8 | +16.1% |
| 2009 | 23.5 | -8.5 | -18.2 | -0.4 | 20.6 | -19.8 | 7.4 | 3.4 | 9.3 | 6.5 | -14.3 | 4.6 | +3.1% |
| 2008 | -6.7 | -3.8 | -7.0 | 2.9 | 0.4 | 1.1 | 9.6 | 7.2 | -9.2 | -5.0 | -6.5 | 9.6 | −9.4% |
| 2007 | 1.6 | 0.2 | 0.8 | 4.3 | -3.8 | -2.5 | -6.7 | -2.6 | 3.0 | 0.5 | -9.5 | 3.3 | −11.8% |
No analyst coverage for this instrument.
No recent headlines.